Ex vivo drug and irradiation sensitivities in hypermutated and unmutated forms of chronic lymphocytic leukemia cells

Leukemia Research

Volumn 27, Issue 4, 2003, Pages 337-341

  Kivekäs, Ilkka ^a,b   Tobin, Gerald ^c   Thunberg, Ulf ^c   Vilpo, Leena ^a,b   Sundström, Christer ^c   Rosenquist, Richard ^c   Vilpo, Juhani ^a,b  

^a JORVI HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chronic lymphocytic leukemia; CLL; Drug sensitivity; Immunoglobulin gene; Somatic hypermutation

Indexed keywords

CHLORAMBUCIL; CISPLATIN; CLADRIBINE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; PREDNISOLONE; SUCCINIC ACID; VERAPAMIL; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; CELL HETEROGENEITY; CELL MUTANT; CELL STRAIN; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SENSITIVITY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; RADIOSENSITIVITY; STRAIN DIFFERENCE; ULTRAVIOLET IRRADIATION; WILD TYPE;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA RAYS; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PROGNOSIS; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; ULTRAVIOLET RAYS;

EID: 0037377091     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00169-8     Document Type: Article

References (27)

1. Ghia P, Caligaris-Cappio F. The origin and nature of chronic lymphocytic leukemia lymphocytes. In: Cheson B, editor. Chronic Lymphoid Leukemias. New York: Marcel Dekker; 2001. p. 63-80.
2. Berek C., Milstein C. Mutation drift and repertoire shift in the maturation of the immune response. Immunol. Rev. 96:1987;23-41.
3. Schroeder H.W. Jr., Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol. Today. 15:1994;288-294.
4. Oscier D.G., Thompsett A., Zhu D., Stevenson F.K. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 89:1997;4153-4160.
5. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L.et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1998;1515-1525.
6. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L.et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1999;1840-1847.
7. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1999;1848-1854.
8. Tobin G., Thunberg U., Johnson A., Thörn I., Söderberg O., Hultdin M.et al. Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 99:2002;2262-2264.
9. Molica S. Prognostic factors in chronic lymphocytic leukemia. In: Cheson B, editor. Chronic lymphoid leukemias. New York: Marcel Dekker; 2001. p. 231-60.
10. Hulkkonen J., Vilpo L., Hurme M., Vilpo J. Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities. Leukemia. 16:2002;178-185.
11. Bennett J., Catovsky D., Daniel M., Flandrin G., Galton D., Gralnick H.et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J. Clin. Pathol. 42:1989;567-584.
12. Karhu R., Knuutila S., Kallioniemi O.P., Siitonen S., Aine R., Vilpo L.et al. Frequent loss of the 11q14-24 region in chronic lymphocytic leukemia: a study by comparative genomic hybridization. Tampere CLL Group. Gene Chromosome Cancer. 19:1997;286-290.
13. Karhu R., Vilpo L., Isola J., Knuutila S., Vilpo J. Cryopreserved chronic lymphocytic leukaemia cells analysed by multi-colour FISH after optimised mitogen stimulation. Gene Chromosome Cancer. 34:2002;345-348.
14. Larramendy M., Siitonen S., Zhu Y., Hurme M., Vilpo L., Vilpo J.et al. Optimized mitogen stimulation induces proliferation of neoplastic B-cells in chronic lymphocytic leukemia: significance for cytogenetic analysis. Cytogenet. Cell Genet. 82:1998;215-221.
15. Koski T., Karhu R., Visakorpi T., Vilpo L., Knuutila S., Vilpo J. Complex chromosomal aberrations in chronic lymphocytic leukemia are associated with cellular drug and irradiation resistance. Eur. J. Haematol. 65:2000;32-39.
16. Kivekäs I., Vilpo L., Vilpo J. Relationships of in vitro sensitivities tested with nine drugs and two types of irradiation in chronic lymphocytic leukemia. Leuk. Res. 26:2002;1035-1041.
17. Bosanquet A.G., Bell P.B. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia. Blood. 87:1996;1962-1971.
18. Vilpo J., Vilpo L., Hulkkonen J., Lankinen M., Kuusela P., Hurme M. Non-specific binding compromises the purification yields of leukemic B-cells in chronic lymphocytic leukemia: prevention by collagen coating. Eur. J. Haematol. 60:1998;65-67.
19. Li A.H., Rosenquist R., Forestier E., Holmberg D., Lindh J., Lofvenberg E.et al. Clonal rearrangements in childhood and adult precursor B acute lymphoblastic leukemia: a comparative polymerase chain reaction study using multiple sets of primers. Eur. J. Haematol. 63:1999;211-218.
20. Myllyperkiö M., Koski T., Vilpo L., Vilpo J. Kinetics of excision repair of UV-induced DNA damage, measured using the comet assay. Mutat. Res. 448:1999;1-9.
21. Myllyperkiö M., Koski T., Vilpo L., Vilpo J. Gamma-irradiation-induced DNA single- and double-strand breaks and their repair in chronic lymphocytic leukemia of variable radiosensitivity. Hematol. Cell Ther. 41:1999;95-103.
22. Koski T., Aine R., Vilpo L., Vilpo J. Cyclosporin A-induced cell kill in vitro in various clinical-hematological types of B cell chronic lymphocytic leukemia. Leuk. Res. 24:2000;805-812.
23. Koski T., Vilpo L., Vilpo J. Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia. Leuk. Res. 23:1999;277-279.
24. Vilpo J., Koski T., Vilpo L. Selective toxicity of vincristine against chronic lymphocytic leukemia cells in vitro. Eur. J. Haematol. 65:2000;1-9.
25. Vilpo J., Koski T., Vilpo L. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia in vitro. Haematologica. 85:2000;806-813.
26. Kröber A., Seiler T., Leupolt E., Döhner H., Stilgenbauer S. IgVH mutated and unmutated B-CLL tumors show distinct genetic aberration patterns. Blood. 96(Suppl.):2000;835a.
27. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H.et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:2001;1625-1638.